Antiobesity medications in active‐duty military personnel
Obesity · 2024
DOI: 10.1002/oby.24136 ↗At a glance
Journal article in Obesity, 2024. Written by Brandon M Roberts and 3 co-authors. Institution: Military Performance Division, US Army Research Institute of Environmental Research, Natick, Massachusetts, USA. Major MEDLINE topics: Military Personnel, Anti-Obesity Agents, Obesity. Cited 2 times so far (Crossref); 5 references.
Abstract (original language)
Over 20% of soldiers have a body mass index (BMI) that exceeds 30 kg/m 2 , and this is an upward trend [1].The Department of Defense spends $1.5 billion annually in obesity-related health care costs for current and former service members and their families, as well as costs to replace unfit personnel.Antiobesity medications (AOMs) may substantially help reduce these costs.In an article in this issue of Obesity, Neuman et al. [2] found that 0.1% of active-duty service members used AOMs.AOMs have been
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Military Performance Division, US Army Research Institute of Environmental Research, Natick, Massachusetts, USA.
- Thermal and Mountain Medicine Division, US Army Research Institute of Environmental Research, Natick, Massachusetts, USA.
- Office of the Senior Scientist, US Army Research Institute of Environmental Research, Natick, Massachusetts, USA.
ORCID profiles: Brandon M Roberts, Adam W Potter
Cite
APA
Roberts, B. M., Potter, A. W., Chin, G. C., & Friedl, K. E. (2024). Antiobesity medications in active‐duty military personnel. Obesity. https://doi.org/10.1002/oby.24136
Vancouver
Roberts BM, Potter AW, Chin GC, Friedl KE. Antiobesity medications in active‐duty military personnel. Obesity. 2024. doi:10.1002/oby.24136
BibTeX
@article{Roberts2024,
author = {Roberts, Brandon M and Potter, Adam W and Chin, Geoffrey C and Friedl, Karl E},
title = {Antiobesity medications in active‐duty military personnel},
journal = {Obesity},
year = {2024},
doi = {10.1002/oby.24136}
}
EUVIMED